Bharat Serums is seen as one of Incepta Vaccine's top competitors. Bharat Serums was founded in Mumbai, Maharashtra} in 1971. Bharat Serums is in the Biotechnology industry. Compared to Incepta Vaccine, Bharat Serums generates $34.3M more revenue.
Incepta Vaccine VS Haffkine
Haffkine is Incepta Vaccine's #2 competitor. Haffkine was founded in 1899, and its headquarters is in Mumbai, Maharashtra. Haffkine competes in the Biotechnology industry. Haffkine has 7,250 fewer employees than Incepta Vaccine.
Incepta Vaccine VS VINS
VINS is Incepta Vaccine's #3 rival. VINS is headquartered in Hyderabad, Andhra Pradesh, and was founded in 1997. Like Incepta Vaccine, VINS also competes in the Biotechnology industry. VINS generates 32% the revenue of Incepta Vaccine.
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 15, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf...
AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in the ong...
Lilly (LLY) reported that 27.7% of Omvoh-treated ulcerative colitis patients achieved comprehensive disease control at one year, versus 14% on placebo....